Advertisement
Screener

Indivior Pharmaceuticals, Inc. (SUPN) Other, 2021

Indivior Pharmaceuticals, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2021-11-05: Form 10-Q; Item Shares outstanding as of 2021-11-01; As filed 53,180,768.
  • 2021-08-06: Form 10-Q; Item Shares outstanding as of 2021-08-02; As filed 53,145,884.
  • 2021-05-07: Form 10-Q; Item Shares outstanding as of 2021-04-30; As filed 53,018,637.
  • 2021-03-08: Form 10-K; Item Shares outstanding as of 2021-02-28; As filed 52,923,107.
FiledFormItemAs filed
2021-11-0510-QShares outstanding as of 2021-11-0153,180,768
2021-08-0610-QShares outstanding as of 2021-08-0253,145,884
2021-05-0710-QShares outstanding as of 2021-04-3053,018,637
2021-03-0810-KShares outstanding as of 2021-02-2852,923,107
2021-03-0810-KPublic float as of 2020-06-30$1.21B
2021-03-0810-KStock registered under Section 12(b)Common Stock, $0.001 Par Value · SUPN · NASDAQ

Similar stocks

Stock NameCountryMarket CapPE Ratio
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38